Encoded Therapeutics
Total Raised
$239.12MInvestors Count
19Funding, Valuation & Revenue
10 Fundings
Encoded Therapeutics has raised $239.12M over 10 rounds.
Encoded Therapeutics's latest funding round was a Series E for on January 11, 2021.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
1/11/2021 | Series E | Undisclosed Investors | ||||
7/22/2020 | Series D | $135M | 7 | |||
6/26/2019 | Series C | $104M | 3 | |||
4/17/2017 | Incubator/Accelerator - II | |||||
1/26/2017 | Seed VC |
Date | 1/11/2021 | 7/22/2020 | 6/26/2019 | 4/17/2017 | 1/26/2017 |
|---|---|---|---|---|---|
Round | Series E | Series D | Series C | Incubator/Accelerator - II | Seed VC |
Amount | $135M | $104M | |||
Investors | Undisclosed Investors | ||||
Valuation | |||||
Revenue | |||||
Sources | 7 | 3 |
Encoded Therapeutics Investors
19 Investors
Encoded Therapeutics has 19 investors. ARCH Venture Partners invested in Encoded Therapeutics's Series D funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
1/26/2017 | 7/22/2020 | 3 Seed VC, Series C (2019), Series D (2020) | Venture Capital | Illinois | ||
6/26/2019 | 7/22/2020 | 2 Series C, Series D (2020) | Hedge Fund | Massachusetts | ||
6/26/2019 | 7/22/2020 | 2 Series C, Series D (2020) | Hedge Fund | New York | ||
Venture Capital | California | |||||
Venture Capital | California |
First funding | 1/26/2017 | 6/26/2019 | 6/26/2019 | ||
|---|---|---|---|---|---|
Last Funding | 7/22/2020 | 7/22/2020 | 7/22/2020 | ||
Investor | |||||
Rounds | 3 Seed VC, Series C (2019), Series D (2020) | 2 Series C, Series D (2020) | 2 Series C, Series D (2020) | ||
Board Seats | |||||
Type | Venture Capital | Hedge Fund | Hedge Fund | Venture Capital | Venture Capital |
Location | Illinois | Massachusetts | New York | California | California |
Loading...